Yingjiang Zhou

机构：Merck & Co., Inc., Rahway, NJ, USA (United States), Quantitative BioSciences

发表论文 44 篇 · 总被引 3844 次 · h-index 25

代表论文

• A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects (2016 · Cell Metabolism · 被引 493)
• Leptin signaling and leptin resistance (2013 · Frontiers of Medicine · 被引 409)
• FGF21 Regulates Sweet and Alcohol Preference (2015 · Cell Metabolism · 被引 341)
• XBP1s Is an Anti-lipogenic Protein (2016 · Journal of Biological Chemistry · 被引 73)
• Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5) (2015 · Scientific Reports · 被引 71)
• Mice deleted for GPAT3 have reduced GPAT activity in white adipose tissue and altered energy and cholesterol homeostasis in diet-induced obesity (2014 · American Journal of Physiology-Endocrinology and Metabolism · 被引 57)